These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28617439)

  • 1. Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.
    Paul D; Ghorai S; Dinesh US; Shetty P; Chattopadhyay S; Santra MK
    Cell Death Dis; 2017 Jun; 8(6):e2882. PubMed ID: 28617439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphase-promoting complex/cyclosome-Cdc-20 promotes Zwint-1 degradation.
    He Y; Li R; Gu L; Deng H; Zhao Y; Guo Y; Yu S; Wang G
    Cell Biochem Funct; 2020 Jun; 38(4):451-459. PubMed ID: 31945194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
    Choppara S; Malonia SK; Sankaran G; Green MR; Santra MK
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):998-1003. PubMed ID: 29343641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
    Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
    PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdc20 mediates D-box-dependent degradation of Sp100.
    Wang R; Li KM; Zhou CH; Xue JL; Ji CN; Chen JZ
    Biochem Biophys Res Commun; 2011 Dec; 415(4):702-6. PubMed ID: 22086178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphase-promoting complex/cyclosome participates in the acute response to protein-damaging stress.
    Ahlskog JK; Björk JK; Elsing AN; Aspelin C; Kallio M; Roos-Mattjus P; Sistonen L
    Mol Cell Biol; 2010 Dec; 30(24):5608-20. PubMed ID: 20937767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
    Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
    J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of human RAP80 is cell cycle regulated by Cdc20 and Cdh1 ubiquitin ligases.
    Cho HJ; Lee EH; Han SH; Chung HJ; Jeong JH; Kwon J; Kim H
    Mol Cancer Res; 2012 May; 10(5):615-25. PubMed ID: 22426463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20.
    Lim HJ; Dimova NV; Tan MK; Sigoillot FD; King RW; Shi Y
    Mol Cell Biol; 2013 Nov; 33(21):4166-80. PubMed ID: 23979597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Cdc20 for cancer therapy.
    Jeong SM; Bui QT; Kwak M; Lee JY; Lee PC
    Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188824. PubMed ID: 36243246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy to block mitotic progression for targeted therapy.
    Chi JJ; Li H; Zhou Z; Izquierdo-Ferrer J; Xue Y; Wavelet CM; Schiltz GE; Zhang B; Cristofanilli M; Lu X; Bahar I; Wan Y
    EBioMedicine; 2019 Nov; 49():40-54. PubMed ID: 31669221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity.
    Singh S; Sreenath K; Pavithra L; Roy S; Chattopadhyay S
    Int J Biochem Cell Biol; 2010 Jul; 42(7):1105-14. PubMed ID: 20097305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdc20 proteolysis requires p38 MAPK signaling and Cdh1-independent APC/C ubiquitination during spindle assembly checkpoint activation by cadmium.
    Yen AH; Yang JL
    J Cell Physiol; 2010 May; 223(2):327-34. PubMed ID: 20054826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin E3 ligase APC/C
    Meng L; Dong R; Mi W; Qin K; Ouyang K; Sun J; Li J
    J Biol Chem; 2024 Jul; 300(7):107448. PubMed ID: 38844135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65.
    Du Y; Zhang M; Liu X; Li Z; Hu M; Tian Y; Lv L; Zhang X; Liu Y; Zhang P; Zhou Y
    EMBO Rep; 2021 Sep; 22(9):e52576. PubMed ID: 34382737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APC/C (Cdh1) controls the proteasome-mediated degradation of E2F3 during cell cycle exit.
    Ping Z; Lim R; Bashir T; Pagano M; Guardavaccaro D
    Cell Cycle; 2012 May; 11(10):1999-2005. PubMed ID: 22580460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
    Pavithra L; Singh S; Sreenath K; Chattopadhyay S
    Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Cdc20 as a novel cancer therapeutic strategy.
    Wang L; Zhang J; Wan L; Zhou X; Wang Z; Wei W
    Pharmacol Ther; 2015 Jul; 151():141-51. PubMed ID: 25850036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.